RUTH ADELMAN: Open Payments
NPI 1760620454 · TEANECK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 13 payments from 9 companies in 2025. Trend: 2023 $391 · 2024 $839 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $364 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $260 |
| UCB, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| GENZYME CORPORATION | 1 | $100 |
| SCPHARMACEUTICALS INC. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Boston Scientific Corporation | 1 | $25 |
Products named: VRAYLAR, CAPLYTA, Nayzilam, Ozempic, UZEDY, CEREZYME, FUROSCIX, OJJAARA.
Industry payments across NJ — which companies pay providers there.
